These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 14706330)
1. No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cells. Weng AP; Aster JC Cancer Cell; 2003 Dec; 4(6):417-8. PubMed ID: 14706330 [TBL] [Abstract][Full Text] [Related]
2. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Sicinska E; Aifantis I; Le Cam L; Swat W; Borowski C; Yu Q; Ferrando AA; Levin SD; Geng Y; von Boehmer H; Sicinski P Cancer Cell; 2003 Dec; 4(6):451-61. PubMed ID: 14706337 [TBL] [Abstract][Full Text] [Related]
3. The cyclin D3 knockout: a pound of redundancy with a dash of tissue specificity. Diehl JA Cancer Biol Ther; 2004 Feb; 3(2):162-4. PubMed ID: 14752277 [TBL] [Abstract][Full Text] [Related]
4. [Expressions of cyclins A, B1, D3, and E in asynchronous and synchronous MOLT-4 cells of G1 phase]. Yu CZ; Feng YD; Tao DD; Yu Y; Wu JH; Gong JP Ai Zheng; 2005 Feb; 24(2):170-4. PubMed ID: 15694027 [TBL] [Abstract][Full Text] [Related]
5. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma. Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668 [TBL] [Abstract][Full Text] [Related]
6. Induction of G1 arrest by down-regulation of cyclin D3 in T cell hybridomas. Miyatake S; Nakano H; Park SY; Yamazaki T; Takase K; Matsushime H; Kato A; Saito T J Exp Med; 1995 Aug; 182(2):401-8. PubMed ID: 7629502 [TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: early induction of cyclin D3. Engedal N; Gjevik T; Blomhoff R; Blomhoff HK J Immunol; 2006 Sep; 177(5):2851-61. PubMed ID: 16920920 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535 [TBL] [Abstract][Full Text] [Related]
9. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes. Sicinska E; Lee YM; Gits J; Shigematsu H; Yu Q; Rebel VI; Geng Y; Marshall CJ; Akashi K; Dorfman DM; Touw IP; Sicinski P Mol Cell Biol; 2006 Nov; 26(21):8052-60. PubMed ID: 16954383 [TBL] [Abstract][Full Text] [Related]
10. Evidence for coordinated interaction of cyclin D3 with p21 and cdk6 in directing the development of uterine stromal cell decidualization and polyploidy during implantation. Tan J; Raja S; Davis MK; Tawfik O; Dey SK; Das SK Mech Dev; 2002 Feb; 111(1-2):99-113. PubMed ID: 11804782 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1. Teixeira A; Chaverot N; Strosberg AD; Cazaubon S J Neurochem; 2000 Mar; 74(3):1034-40. PubMed ID: 10693934 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase. Bacon CL; Gallagher HC; Haughey JC; Regan CM J Neurochem; 2002 Oct; 83(1):12-9. PubMed ID: 12358724 [TBL] [Abstract][Full Text] [Related]
13. Induction and expression of cyclin D3 in human pancreatic cancer. Ebert MP; Hernberg S; Fei G; Sokolowski A; Schulz HU; Lippert H; Malfertheiner P J Cancer Res Clin Oncol; 2001 Jul; 127(7):449-54. PubMed ID: 11469683 [TBL] [Abstract][Full Text] [Related]
14. Ikaros induces quiescence and T-cell differentiation in a leukemia cell line. Kathrein KL; Lorenz R; Innes AM; Griffiths E; Winandy S Mol Cell Biol; 2005 Mar; 25(5):1645-54. PubMed ID: 15713624 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation. Gutzkow KB; Låhne HU; Naderi S; Torgersen KM; Skålhegg B; Koketsu M; Uehara Y; Blomhoff HK Cell Signal; 2003 Sep; 15(9):871-81. PubMed ID: 12834812 [TBL] [Abstract][Full Text] [Related]
16. Long-term cultured IL-2-dependent T cell lines demonstrate p16(INK4a) overexpression, normal pRb/p53, and upregulation of cyclins E or D2. Siwicki JK; Hedberg Y; Nowak R; Lodén M; Zhao J; Landberg G; Roos G Exp Gerontol; 2000 May; 35(3):375-88. PubMed ID: 10832057 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405 [TBL] [Abstract][Full Text] [Related]
18. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794 [TBL] [Abstract][Full Text] [Related]
19. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry. Gong J; Bhatia U; Traganos F; Darzynkiewicz Z Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853 [TBL] [Abstract][Full Text] [Related]
20. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]